EUVIMEDEUVIMED entdecken
Crossref

Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels

Julie Heremans, Robin Maximilian Awad, Jessica Bridoux, Thomas Ertveldt, Vicky Caveliers, Annemieke Madder, Richard Hoogenboom, Nick Devoogdt, Steven Ballet, Sophie Hernot, Karine Breckpot, Charlotte Martin

European Journal of Pharmaceutics and Biopharmaceutics · 2024-03 · 196 · 114183

DOI: 10.1016/j.ejpb.2024.114183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024-03. Verfasst von Julie Heremans und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Group of Organic Chemistry, Vrije Universiteit Brussel, B-1050 Brussels, Belgium. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Melanoma. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek, VUB University, Kom op tegen kanker.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesMelanomaHumansAnimalsMiceDelayed-Action PreparationsB7-H1 AntigenHydrogelsPeptidesAntibodies, Monoclonal

Stichwörter der Autor:innen

Fluorescence imagingPeptide hydrogelProgrammed death-ligand 1Single-domain antibodySubcutaneous injectionSustained release

Substanzen

Single-Domain AntibodiesDelayed-Action PreparationsB7-H1 AntigenHydrogelsPeptidesAntibodies, Monoclonal

Autor:innen und Institutionen

  • Research Group of Organic Chemistry, Vrije Universiteit Brussel, B-1050 Brussels, Belgium.
  • Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
  • In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
  • Organic and Biomimetic Chemistry Research Group, Ghent University, 9000 Ghent, Belgium.
  • Supramolecular Chemistry Group, Centre of Macromolecular Chemistry (CMaC), Department of Organic and Macromolecular Chemistry, Ghent University, 9000 Ghent, Belgium.

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • VUB University
  • Kom op tegen kanker
  • Melanoma Research Alliance
  • Norges Forskningsråd
  • Stichting Tegen Kanker

Zitieren

APA

Heremans, J., Maximilian Awad, R., Bridoux, J., Ertveldt, T., Caveliers, V., Madder, A., Hoogenboom, R., Devoogdt, N., Ballet, S., Hernot, S., Breckpot, K., & Martin, C. (2024). Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels. European Journal of Pharmaceutics and Biopharmaceutics, 196, 114183. https://doi.org/10.1016/j.ejpb.2024.114183

Vancouver

Heremans J, Maximilian Awad R, Bridoux J, Ertveldt T, Caveliers V, Madder A, et al. Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels. European Journal of Pharmaceutics and Biopharmaceutics. 2024;196:114183. doi:10.1016/j.ejpb.2024.114183

BibTeX
@article{Heremans2024,
  author = {Heremans, Julie and Maximilian Awad, Robin and Bridoux, Jessica and Ertveldt, Thomas and Caveliers, Vicky and Madder, Annemieke and Hoogenboom, Richard and Devoogdt, Nick and Ballet, Steven and Hernot, Sophie and Breckpot, Karine and Martin, Charlotte},
  title = {Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2024},
  volume = {196},
  pages = {114183},
  doi = {10.1016/j.ejpb.2024.114183}
}
Kostenlos starten →